t-9

T9 peptide (SKTFNTHPQSTP) 是一种特定肌肉靶向的肽.它与 C2C12 成肌细胞具有高度结合能力.当T9 peptide 与寡核苷酸结合时,其对心脏和股四头肌的靶向特异性得到增强,但对肾、肝和膈肌的靶向作用不明显.

ABT-963 是一种高效和选择性的二取代哒嗪酮环氧合酶-2（LOX2）抑制剂，剂量依赖性地降低卡拉胶痛觉过敏模型中的伤害感受。ABT-963 可用于研究关节炎。

T-900607是一种新型微管蛋白活性剂，通过独特的作用机制破坏微管聚合。t-900607具有心脏毒性。

CU-CPT-9a 是TLR8特异性拮抗剂，IC50值为 0.5 nM。

ML-943 是选择性的、口服活性的MALT1 protease 抑制剂。它可抑制 PBMC 或全血中 IL-2 的分泌，PBMC 中抑制的IC50值为 0.07~0.09 μM，全血中抑制的IC50值为 0.6~0.8 μM)。它具有抗炎作用，可用于研究 FcgR 介导的炎症。

Anti-osteoporosis agent-9 (compound 5b)为N-环丙基-4-((磺酰哌嗪-1-基)甲基)苯酰胺衍生物,具有显著的抗破骨细胞活性.

ent-9-Hydroxy-15-oxokauran-19-oic acid 是一种天然产物，可用于生命科学领域的相关研究。其产品编号为 TN5577，CAS号为 77658-45-8。

(3R)-5,7-Dihydroxy-6-methyl-3-(4'-hydroxybenzyl)chroman-4-one is a natural product

ent-9-Hydroxy-15-oxo-16-kauren-19-oic acid 是一种天然产物，可用于生命科学领域的相关研究。其产品编号为 TN3956，CAS号为 77658-39-0。

Antiparasitic agent-9 (compound 47) is a highly active and orally administered antiparasitic agent, exhibiting potent antiparasitic efficacy against the human parasite [1].

Antioxidant agent-9 是一种肽，序列是Asp-Trp。Antioxidant agent-9 具有抗氧化活性。Antioxidant agent-9 也是一种潜在的SARS-CoV-2抗病毒剂，其亲和力强度与 Chloroquine 和 Favipiravir 相当。

Antitumor agent-93 (化合物 7D) 为抗癌剂，对MDA-MB-231与HCT-116等多种肿瘤细胞系生长抑制效果显著。

Antileishmanial agent-9 (compound 16c) exhibits potent and selective activity against Leishmania donovani (L. donovani) with an IC50 value of 4.01 μM. In addition, this compound demonstrates relatively low cytotoxicity in L-6 cells, with an IC50 value of 40.1 μM [1].

AT-9010 triethylamine, a triphosphate active metabolite of AT-527, is a potent inhibitor of the NiRAN enzyme, which is essential for viral replication. It effectively inhibits SARS-CoV-2 replication.

AT-9283, a multi-targeted kinase inhibitor, is used potentially for the treatment of multiple myeloma.

3-Hydroxylanost-9(11)-24-dien-26-oic acid 是一种天然产物，可用于生命科学领域的相关研究。其产品编号为 TN2949，CAS号为 129724-83-0。

Antitumor agent-92为一种淫羊藿素衍生物，能够引起细胞周期在G0 G1期的停滞，并诱导细胞凋亡。该化合物展现出在肝细胞癌(HCC)研究中的应用潜力。

Antitumor agent-97（化合物 42）是一种有效抑制MGC 803细胞增殖与自噬（autophagy）并诱导细胞凋亡（apoptosis）的抗癌剂。该化合物还可增强MGC 803细胞中ROS的积累，适用于癌症研究。

Antitumor agent-96 (Compound D34) 为一种有效的MRE11抑制剂，能够结合MRE11并通过抑制其内切酶功能来下调HR通路，进而诱导CM细胞的凋亡(apoptosis)。

ABT-925, also known as A-37203, BSF-201640; DAT-201; Lu-201640; and A-437203, is a selective dopamine D3 receptor (DRD3) antagonist with an approximately 100-fold higher in vitro affinity for dopamine D₃ versus D₂ receptors. ABT-925 was tested in schizophrenia. ABT-925 is a selective dopamine D₃ receptor antagonist with an approximately 100-fold higher in vitro affinity for dopamine D₃ versus D₂ receptors.

NCTT-956 是一种高效且特异性的血小板 12-脂氧合酶 (12-LOX) 活性抑制剂。

MRT-92 is a potent and selective Smoothened (Smo) receptor inhibitor. MRT-92 displays subnanomolar antagonist activity against Smo in various Hh cell-based assays. MRT-92 inhibits rodent cerebellar granule cell proliferation induced by Hh pathway activation through pharmacologic (half maximal inhibitory concentration [IC50] = 0.4 nM) or genetic manipulation. Smo is the target of anticancer drugs that bind to a long and narrow cavity in the 7-transmembrane (7TM) domain.

STINGagonist-9 (Compound 45) 是一种有效的STING 激动剂，对 h-STING 和 m-STING 的EC50值分别为 1.2 nM 和 32.82 μM。STINGagonist-9 具有抗肿瘤活性。

Anti-CD71 Antibody (OKT-9)，一种小鼠IgG1, κ 类型的嵌合抗体，专门针对CD71(人源)。该抗体的同型对照为Mouse IgG1 kappa, Isotype Control。